Company Filing History:
2 out of 6,850 
1 out of 166 
1 out of 2 Years Active: 1994-1998
Title: The Innovations of Clemens Sorg
Introduction
Clemens Sorg is a notable inventor based in Munster, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of inflammatory conditions and related diseases. With a total of 4 patents, Sorg's work has had a profound impact on medical research and therapeutic methods.
Latest Patents
Sorg's latest patents include groundbreaking inventions that focus on mediating inflammation. One of his notable inventions is a cytokine that mediates inflammation, which concerns polypeptides with an apparent molecular weight of around 160 kD. These polypeptides serve as mediators or precursors for mediators of inflammation, along with their derivatives such as mutants and fragments. The patent also covers processes for their preparation, DNAs and hybrid vectors coding for the polypeptides and derivatives, and host cells transformed with such hybrid vectors. Additionally, it includes polyclonal and monoclonal antibodies specific for the polypeptides or their derivatives, as well as diagnostic and therapeutic methods for inflammatory conditions and Hodgkin lymphomas.
Another significant patent involves DNAs encoding human macrophage migration inhibition factor related polypeptides, specifically MRP-8 and MRP-14. This invention details processes for their preparation, mRNAs, DNAs, and hybrid vectors coding for those polypeptides. It also includes hosts transformed with such a hybrid vector, monoclonal and polyclonal antibodies to those polypeptides, and diagnostic methods for inflammatory conditions and cystic fibrosis.
Career Highlights
Throughout his career, Clemens Sorg has worked with prominent companies in the pharmaceutical industry, including Ciba-Geigy Corporation and Novartis Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Sorg has collaborated with notable colleagues such as Karel Gerrit Odink and Nico Cerletti. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Clemens Sorg's contributions to the field of biotechnology through his patents and collaborations have significantly advanced our understanding of inflammatory conditions. His work continues to inspire future innovations in medical research and therapeutic applications.